HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Exceptionally good response to sodium valproate in patients with recurrent Sydenham's chorea].

Abstract
Sydenham's chorea is the most common acquired cause of chorea in the third world. We report a case of recurrent chorea successfully treated with sodium valproate. Miss A.C, aged 16, with a history of recurrent angina reported an episode of choreic movements 2 years before requiring treatment with haloperidol and prevention of rheumatic fever. The patient interrupted her treatment with occurrence of a relapse a few months later. Brain MRI and transthoracic ultrasound were normal. Preventive treatment with extencilline and haloperidol was restarted without any improvement, hence the treatment with sodium valproate. The patient responded very well after 2 months of treatment, without recurrence at 3 years' follow-up. The treatment of Sydenham's chorea was based on neuroleptics. Recent studies advocate the use of other more effective and better tolerated molecules.
AuthorsSiham Bouchal, Ouarda Ouali, Mouhamed Faouzi Belahsen
JournalThe Pan African medical journal (Pan Afr Med J) Vol. 27 Pg. 212 ( 2017) ISSN: 1937-8688 [Electronic] Uganda
Vernacular TitleRéponse spectaculaire au valproate de sodium d’une chorée de Sydenham récurrente.
PMID28979614 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticonvulsants
  • Valproic Acid
  • Haloperidol
Topics
  • Adolescent
  • Anticonvulsants (therapeutic use)
  • Chorea (drug therapy, physiopathology)
  • Female
  • Follow-Up Studies
  • Haloperidol (therapeutic use)
  • Humans
  • Recurrence
  • Rheumatic Fever (prevention & control)
  • Treatment Outcome
  • Valproic Acid (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: